Geminin has a dual role in the regulation of DNA replication: it inhibits replication factor CDT1 14 activity during the G2 phase of the cell cycle and promotes its accumulation at the G2/M 15 transition. In this way Geminin prevents DNA re-replication during G2 phase and ensures that 16 DNA replication is efficiently executed in the next S phase. CDT1 was shown to associate with 17 SKP2, the substrate recognition factor of the SCF ubiquitin ligase complex. We investigated the 18 interplay between these three proteins in cancer cell lines. We show that Geminin, CDT1 and 19 SKP2 could possibly form a complex and propose the putative regions of CDT1 and Geminin 20 involved in the binding. We also show that, despite the physical interaction, SKP2 depletion does 21 not substantially affect CDT1 and Geminin protein levels. Moreover, we show that while 22
cells. 17
We observed that Geminin associates with SKP2, likely via CDT1, and mapped the putative 18 regions of Geminin and CDT1 involved in the binding. Despite the physical interaction, SKP2 19 levels do not appreciably affect CDT1 and Geminin levels neither during the normal cell cycle 20 nor under conditions of CDT1 instability. These results indicate that, despite its previously 21 reported ability to ubiquitinate CDT1, SKP2 is not the most important factor in the regulation of 22 CDT1 and Geminin proteins levels during G2 phase. Moreover we observed that SKP2 levels, 23
Plasmids for human CDT1 and human Geminin were previously constructed (Ballabeni et al. by using the Calcium Phosphate transfection method (for the experiment shown in Fig. 1B, 1C , 10 2A, 4D, S1, S4A, S4B, S4C and S4D). Transfections of siRNA were performed using 11
Oligofectamine (Invitrogen); Opti-MEM Reduced Serum Medium (Invitrogen) was used for the 12 preparation of the siRNA mixtures and then added to the cells in presence of DMEM containing 13 10% fetal bovine serum. 14 15
Immunoprecipitations and western blotting analyses 16
ANTI-FLAG M2 Affinity Gel from Sigma (#A2220) was used for immunoprecipitations of 17 FLAG-tagged SKP2. Antibodies for HA, Cyclin A, Cyclin B and CDC7 described above were 18 used to immunoprecipitate HA-CDT1, Cyclin A, Cyclin B and CDC7, respectively. 19
Immunoprecipitated and co-immunoprecipitated proteins were detected by western blotting 20 analysis after gel separation, transfer to nitrocellulose membranes and primary hybridizations 21 with the antibodies described above. Secondary hybridizations were performed with HRP-22 conjugated antibodies for ECL detection or with infrared probe-conjugated antibodies for 23 detection with Odyssey Infra-red imaging system (Li-Cor). We did not observe differences 1 between the two detection methods with regard to protein detection. Total protein concentrations 2 were usually quantified by Bradford protein assays to load equal amount of protein in each lane 3 of the gels. Equal protein loadings, as well as the quality of the transfer, were also verified by 4
Ponceau staining of the nitrocellulose membranes. 5 6
Kinase assays 7
For in vitro kinase reactions the recombinant GST-CDT1 was purified from E. coli and used as a 8 substrate. Reactions were completed with 0.1 mM ATP, 5 mCi g-32 ATP (Amersham 9
Biosciences) in the following buffer: 50 mM Hepes/KOH (pH 7.6), 150 mM NaCl, 2.5 mM 10 EGTA, 1 mM EDTA, 1 mM dithiothreitol, 0.1% Tween 20, 10% glycerol, 1 mM NaF and 11 protease inhibitors. The reactions were conducted at 30 °C for 30 minutes with moderate shaking 12 and stopped with Laemmli buffer. After separation on 10% polyacrilamide gels and transfer to 13 nitrocellulose membranes, the phosphorylated CDT1 was detected by autoradiography. 14 Recombinant Geminin (either cleaved or not-cleaved from GST) and p53 (cleaved from Maltose 15
Binding Protein moiety) were purified from E. coli and used as substrates for kinase assays 16 shown in Fig. S3 . 17
18

Results
19
CDT1 and Geminin association with SKP2 in vivo 20
It was previously shown that CDT1 binds to SKP2 Geminin proteins tagged at their N-terminals with FLAG-and Myc-epitopes, respectively. As 1 shown in Fig. 1A exogenous Geminin can associate with SKP2 immunoprecipitate (Fig. 1A) . 2
Since under these experimental conditions we were not able to co-immunoprecipitate 3 endogenous Geminin, we decided to increase the expression of exogenous SKP2. To this 4 purpose, we used a HeLa cell line stably expressing FLAG-tagged SKP2 with Myc-tagged 5
Geminin transiently expressed as before. Western blotting analysis showed that also endogenous 6
Geminin could associate with exogenous SKP2 (Fig. 1B) . Interestingly, the co-expression of 7 CDT1 led to increased levels of Geminin associated with SKP2 (Fig. 1B) . This observation led 8 us to hypothesize that binding between Geminin and SKP2 is mediated by CDT1. To test this 9 hypothesis in vivo, we took advantage of the fact that CDT1 levels drastically decrease in 10 with UV. 15' after irradiation, we lysed the cells, immunoprecipitated for FLAG and performed 13 western blotting analysis. As expected CDT1 decreased in response to UV, but not when cells 14 were co-treated with MG132 (Fig. 1C) . Interestingly, despite there were not major changes in 15
Geminin levels after UV treatment, the fraction associated with FLAG-SKP2 dramatically 16 diminished in cells treated with UV, but not in cells co-treated with MG132 (Fig. 1C) . Taken 17 together these results show that not only CDT1, but also Geminin could physically interact with 18 SKP2. These data suggest that the three proteins could possibly associate in the same molecular 19 complex with CDT1 mediating the interaction between Geminin and SKP2 (Fig. 1D) . were not able to interact with SKP2 ( Fig. 2A and 2B ). We also noticed that endogenous Geminin 5 was not co-immunoprecipitated when the exogenous versions of Geminin competent in SKP2 6 binding were co-expressed ( Fig. 2A) , suggesting that ectopically expressed Geminin prevents results confirm that Geminin could possibly bind to SKP2 through its association with CDT1. 10
11
Characterization of the regions of CDT1 involved in the association 12
We then further characterized the interaction between CDT1 and SKP2. To this purpose, we 13 or mutated on Serine 31, was used as a substrate. We observed that the WT version was 6 phoshorylated very efficiently while the mutated version was phosphorylated much less 7 efficiently by cyclin A and cyclin B-associated kinase activities ( Fig. 3C and 3D ). Because 8 CDC7 kinase was also reported to be able to bind to and phosphorylate CDT1 (Ballabeni et al. 9
2009) (and Fig. S1 ), we performed a similar kinase assay after immunoprecipitation of CDC7 10 kinase overexpressed in HeLa cells. Again, we observed that the mutant was phosphorylated 11 much less efficiently (Fig. 3E) . These results suggest that Serine 31 of CDT1, located in the N-12 terminal regulatory region, could be an in vivo phosphorylation site for CDK and CDC7 kinases. Moreover, these results show that Serine 31, similarly to Threonine 29, is likely involved in the 14 regulation of the association between CDT1 and SKP2 (Fig. 3F) . 15
16
SKP2 levels do not substantially affect CDT1 and Geminin levels 17
It was previously reported that SKP2 protein binds to and ubiquitinates CDT1 (Kondo et al. was suggested that SKP2 regulates CDT1 levels during G2 phase (Nishitani et al. 2006) . 20
Therefore, we tested if SKP2 affects CDT1 protein levels in G2 phase and mitosis. To this 21 purpose, we used siRNA to decrease the levels of SKP2. We synchronized U2OS cells before 22 treating them with siRNA for SKP2 and collecting them in the G2 phase (Fig. 4A ). Cells were 23 grown with and without the protein synthesis inhibitor cycloheximide for 1 hour before 1 harvesting. Despite the strong decrease in SKP2 levels, no substantial change in CDT1 protein 2 levels was observed, either in presence or absence of cycloheximide (Fig. 4B) . We also tested if 3 a decrease in SKP2 levels can change CDT1 levels in G2 and mitosis after experimental 4 depletion of Geminin, a condition that leads to decrease of CDT1 levels (Ballabeni et al. 2004 ; 5
Ballabeni et al. 2013). To this purpose, we treated U2OS cells with siRNA for SKP2 and/or 6 Geminin and, after synchronization, collected them at the end of the G2 phase or mitosis (Fig.  7 S2A). We observed that depletion of SKP2 did not affect the levels of CDT1 protein in G2 phase 8 and mitosis, either with normal or decreased levels of Geminin protein (Fig. S2A ). To further 9 corroborate these results, we repeated the experiment but this time we decreased the duration of 10 the siRNA treatment to prevent any possible small alteration of the cell cycle structure. We 11 therefore synchronized and treated U2OS cells with siRNA at the S/G2 transition by using a 12 previously developed protocol (Ballabeni et al. 2004) (Fig. 4C ) and we then collected the cells 13 arrested in mitosis. We observed again that depletion of SKP2 protein did not affect the levels of 14 CDT1 protein either under normal or decreased levels of Geminin protein (Fig. 4D) . Geminin 15 levels, also, were not altered by the depletion of SKP2 (Fig. 4B, 4D and S2A ). Finally, we tested 16 if SKP2 depletion prevents CDT1 decrease after UV irradiation. To this purpose, we treated 17 U2OS cells with siRNA for SKP2, synchronized them in G2 phase and treated them with a UV 18 dose of 30 J/m 2 for 45 minutes. We observed that depletion of SKP2 protein did not affect the 19 levels of CDT1 after UV irradiation (Fig. S2B) . We also observed that SKP2, similarly to CDT1, 20 is significantly decreased after UV irradiation (Fig. S2B) . In addition we noticed that SKP2 21 levels, similarly to CDT1 levels, are decreased when Geminin levels are decreased (Fig. 4D and  22 S2A); however, differently from CDT1, the decrease of SKP2 levels seems to be due to an 23 indirect effect of the siRNA transfection (Fig. S3 ). Overall these results indicate that, despite 1 SKP2 protein likely physically interacts with CDT1 and Geminin proteins, it is not the most 2 important factor in the regulation of their levels, under either physiological or non-physiological 3 conditions. were synchronized in mitosis and released in G1 phase for several hours (Fig. 5A ). We observed 10 that, while Geminin, as expected, was almost undetectable during G1, SKP2 protein levels were 11 relatively abundant (Fig. 5A) . We also checked the levels of SKP2 on chromatin. We noticed 12 that whereas CDT1 was, as expected, present in the chromatin-containing fraction after mitotic than Geminin levels during the M-G1 transition. Then, to test the levels of SKP2 protein in G2 17 and mitosis (the only phases in which both CDT1 and Geminin are present), we synchronized 18
HeLa cells in these two phases. We noticed that all three proteins are present during G2 and 19 mitosis (Fig. 5B) . In parallel, we also treated the cells for 1 hour with the proteasome inhibitor 20 MG132. We observed that only CDT1 protein levels were significantly affected by the inhibition 21 of the proteasome (Fig. 5B) , indicating that SKP2 and Geminin turnover is slow during G2 and 22 mitosis. Moreover, we also released the cells in G1 phase for 1 hour. Again, we noticed that 23 whereas Geminin levels significantly decreased, SKP2 levels did not (Fig. 5B) . We also noticed 1 that the addition of the proteasome inhibitor MG132 during G1 altered the levels of CDT1 and 2
Geminin much more than the levels of SKP2 (Fig. 5B) , indicating that the turnover of SKP2 3 during G1 is much slower. To confirm that SKP2 protein is present in G1 and has a slow 4 turnover, we also tested another cell line. To this purpose, we synchronized U2OS cells in 5 mitosis and released them for 3 hours before treating them with and without the proteasome 6 inhibitor MG132 for 1 hour. In agreement with the previous results, we noticed that SKP2 7 protein is present in G1 and has a slow turnover compared to CDT1 and Geminin (Fig. 5C) . (Fig. 5D) . led us to hypothesize that SKP2 indeed might have a role in regulating CDT1 levels in G2 and 19 mitosis. On the contrary, we have observed that SKP2 depletion does not substantially affect 20 CDT1 levels in G2 phase and mitosis, even when CDT1 levels are experimentally decreased 21 either by Geminin depletion or UV irradiation. Given that SKP2 protein is not completely 22 depleted from the cells after siRNA treatment, we cannot totally rule out the possibility that only 23 minimal levels of SKP2 are sufficient to regulate the levels of CDT1. However, considering that 1 the depletion of SKP2 was very effective in our experimental conditions, we can postulate that 2 SKP2 is most likely not a major regulator of CDT1 turnover during G2 and mitosis. It is possible 3 that multiple ubiquitin ligases regulate CDT1 turnover during G2 and mitosis and that only the 4 simultaneous inhibition of all these activities would affect CDT1 levels. 5
In this report we have also shown that SKP2, CDT1 and Geminin, as previously proposed 6 (Takeda et al. 2005 ), might form a complex inside the cells. Our data suggest that CDT1 might 7 function as a bridge between SKP2 and Geminin. We have also shown that the mutation of 8
Serine 31 in a SP motif, which affects the phosphorylation by CDK and CDC7 kinases in vitro, 9 is probably involved in the association with SKP2 in vivo (this is different from what proposed in 10 a previous report (Takeda et al. 2005 ) and we think that the discrepancy is plausibly due to the 11 slightly different experimental conditions). Whereas the SP motif was already known to be a 12 phosphorylation site for CDK kinases, the same was not reported for CDC7 kinase. Indeed we 13 observed that CDC7 kinase is able to in vitro phosphorylate also other recombinant proteins on 14 SP motifs, including Geminin and p53 (Fig. S4 and data not shown); these results suggest that 15 this motif could possibly be a phosphorylation site in vivo. 16 Moreover, our results show that SKP2 is present throughout the cell cycle in the tested cancer 17 cell cells. Thus, while the interaction between the three proteins likely occur only in G2 phase 18 and mitosis, CDT1 and SKP2 could perhaps interact also in G1 phase in these cancer cells (Fig.  19 
5D). 20
Future studies will have to shed light on the functional role of the putative SKP2-CDT1-Geminin 21 physical interaction and to elucidate the ubiquitin ligases involved in the rapid turnover of CDT1 22 protein during G2 phase. Future investigations will also be important to clarify the significance 23 of SKP2 protein presence during the G1 phase of some cancer cell types. This information will 1 be useful to advance our understanding of the molecular mechanisms regulating cell cycle and 2 cell transformation. 3 4
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